News
GlobalData on MSN16h
Veraxa and OmniAb to develop bispecific ADC tumour programmeVeraxa Biotech has entered a joint discovery partnership with OmniAb tp develop a bispecific antibody drug conjugate (bsADC) ...
Starting at 7:30 p.m. inside the Providence Farm Chapel, the show is an entirely acoustic, unplugged, candlelit performance.
The FDA's Fast Track designation has potential to accelerate drug development and review process for ADRX-0706 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results